1. Home
  2. RLYB vs CREX Comparison

RLYB vs CREX Comparison

Compare RLYB & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • CREX
  • Stock Information
  • Founded
  • RLYB 2018
  • CREX N/A
  • Country
  • RLYB United States
  • CREX United States
  • Employees
  • RLYB N/A
  • CREX N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • CREX EDP Services
  • Sector
  • RLYB Health Care
  • CREX Technology
  • Exchange
  • RLYB Nasdaq
  • CREX Nasdaq
  • Market Cap
  • RLYB 46.1M
  • CREX 46.8M
  • IPO Year
  • RLYB 2021
  • CREX N/A
  • Fundamental
  • Price
  • RLYB $1.10
  • CREX $4.40
  • Analyst Decision
  • RLYB Buy
  • CREX Strong Buy
  • Analyst Count
  • RLYB 6
  • CREX 1
  • Target Price
  • RLYB $8.30
  • CREX $10.00
  • AVG Volume (30 Days)
  • RLYB 53.7K
  • CREX 31.4K
  • Earning Date
  • RLYB 11-07-2024
  • CREX 11-07-2024
  • Dividend Yield
  • RLYB N/A
  • CREX N/A
  • EPS Growth
  • RLYB N/A
  • CREX N/A
  • EPS
  • RLYB N/A
  • CREX N/A
  • Revenue
  • RLYB $299,000.00
  • CREX $51,426,000.00
  • Revenue This Year
  • RLYB N/A
  • CREX $26.07
  • Revenue Next Year
  • RLYB N/A
  • CREX $19.94
  • P/E Ratio
  • RLYB N/A
  • CREX N/A
  • Revenue Growth
  • RLYB N/A
  • CREX 26.01
  • 52 Week Low
  • RLYB $1.08
  • CREX $1.22
  • 52 Week High
  • RLYB $4.60
  • CREX $5.20
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 45.50
  • CREX 46.23
  • Support Level
  • RLYB $1.09
  • CREX $4.34
  • Resistance Level
  • RLYB $1.18
  • CREX $4.85
  • Average True Range (ATR)
  • RLYB 0.04
  • CREX 0.21
  • MACD
  • RLYB 0.00
  • CREX -0.00
  • Stochastic Oscillator
  • RLYB 9.90
  • CREX 26.23

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: